Old Web
English
Sign In
Acemap
>
authorDetail
>
Jana Doyle
Jana Doyle
Daiichi Sankyo
Medicine
Pathology
Cancer research
Head and neck cancer
Phases of clinical research
3
Papers
19
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Predicting Progression Free Survival after Systemic Therapy in Advanced Head and Neck Cancer: Bayesian regression and Model development
2021
medRxiv
Paul R. Barber
Fabian Flores-Borja
Giovanna Alfano
Kenrick Ng
Gregory Weitsman
Luigi Dolcetti
Rami Mustapha
Felix Wong
Jose Miguel Vicencio
Myria Galazi
James W. Opzoomer
James N. Arnold
Shahram Kordasti
Jana Doyle
Jon Greenberg
Magnus T. Dillon
Kevin J. Harrington
Martin Forster
Anthony C. C. Coolen
Tony Ng
Show All
Source
Cite
Save
Citations (0)
A phase 1 study of MDM2 inhibitor DS-3032b in patients with well/de-differentiated liposarcoma (WD/DD LPS), solid tumors (ST) and lymphomas (L).
2018
Journal of Clinical Oncology
Todd Michael Bauer
Mrinal M. Gounder
Amy Weise
Gary K. Schwartz
Richard D. Carvajal
Prasanna Kumar
Oleg Zernovak
Alida Beck
Jana Doyle
Jeanne Mendell-Harary
Jarema Kochan
Shuquan Chen
Patricia LoRusso
William D. Tap
Neeta Somaiah
David M. Hyman
Funda Meric-Bernstam
David S. Hong
Show All
Source
Cite
Save
Citations (18)
The use of exosome and immune profiling to analyze a phase 2 study on the addition of patritumab or placebo to cetuximab and a platinum agent for recurrent / metastatic head and neck cancer (R/M HNSCC) patients.
2018
Journal of Clinical Oncology
Tony Ng
Fabian Flores-Borja
Giovanna Alfano
Paul R. Barber
Gregory Weitsman
Felix Wong
Jose Miguel Vicencio
Myria Galazi
Jana Doyle
Jonathan Greenberg
Martin Forster
Anthonius Coolen
Show All
Source
Cite
Save
Citations (1)
1